CCO Virtual Annual HIV Symposia: Advances in HIV Treatment, Prevention, and Cure

Register now for this complimentary event!

The annual CCO HIV Symposium returns in 2022 with a topic-based 3-day virtual workshop format, enabling you to learn about all the important clinical advances in your specific area of interest or across all 3 topics of HIV treatment, prevention, and cure. Register for the event and attend 1, 2, or all 3 workshops!

The workshops will focus on the latest updates on each topic through a highly interactive combination of didactic presentations, case-based learning, and expert panel discussions.

Tuesday, September 20, 2022
12:00 – 1:15 PM ET

Wednesday, September 21, 2022
12:00 – 1:15 PM ET

Thursday, September 22, 2022
12:00pm – 12:45pm ET

*The completion of all 3 workshops is required to receive full credit amount


Tuesday, September 20, 2022

Joseph J. Eron, Jr., MD; Monica Gandhi, MD, MPH; Patrick W.G. Mallon, MB, BCh, FRACP

12:00 PM - 12:05 PM Welcome and introduction

12:05 PM - 12:20 PM State-of-the-Art Overview of Key Updates in Initial HIV Treatment

12:20 PM - 12:35 PM Advances in Switch Strategies for Patients With Viral Suppression on Current ART

12:35 PM - 12:45 PM Current Insights on Selecting New Regimens for Patients With Virologic Failure

12:45 PM - 1:15 PM Participant Question and Answer Session


Wednesday, September 21, 2022

Gregory Huhn, MD, MPHTM; Colleen Kelley, MD, MPH; Darrell H. S. Tan, MD, FRCPC, PhD

12:00 PM - 12:05 PM Welcome and introduction

12:05 PM - 12:10 PM State-of-the-Art Overview of PrEP Eligibility and Regimen Selection

12:10 PM - 12:20 PM Key Features of Long-Acting Injectable PrEP: A New Paradigm

12:20 PM - 12:25 PM Current Insights on Population-Specific PrEP Options

12:25 PM - 12:35 PM Moving Toward Greater Equity in HIV Prevention Services

12:35 PM - 12:45 PM Broadening the Prevention Arsenal: STIs and Monkeypox

12:45 PM - 1:15 PM Participant Question and Answer Session


Thursday, September 22, 2022

Katharine J. Bar, MD; David M. Margolis, MD

12:00 PM - 12:05 PM Welcome and introduction

12:05 PM - 12:30 PM State-of-the-Art Overview of Recent Updates and Current Directions in HIV Functional Cure Research  

12:30 PM - 12:45 PM Participant Question and Answer Session


Date / Time
Event Details


Katharine J. Bar, MD

Joseph J. Eron, Jr., MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Gregory Huhn, MD, MPHTM

Associate Professor
Department of Infectious Diseases
Rush University Medical Center
Senior Director of HIV Services
Department of Infectious Diseases
Cook County Health
Chicago, Illinois

Colleen Kelley, MD, MPH

Associate Professor of Medicine
Division of Infectious Diseases
Emory Center for AIDS Research
Emory University
Atlanta, Georgia

Patrick W.G. Mallon, MB, BCh, PhD, FRACP, FRCPI

Professor of Microbial Diseases
Centre for Experimental Pathogen Host Research
University College Dublin
Dublin, Ireland

David M. Margolis, MD

Darrell H. S. Tan, MD, FRCPC, PhD

Associate Professor
Division of Infectious Diseases
University of Toronto
Division of Infectious Diseases
St. Michael's Hospital
Toronto, Canada

Goal Statement
The goal of this activity is to enhance the interprofessional treatment team’s knowledge of cutting-edge HIV treatment, prevention, and cure research and competence in integrating expanding options into individualized management, now and in the future.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, nurse practitioners, and other healthcare professionals who care for persons with or at risk of HIV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Select appropriately individualized regimens for each patient when initiating ART, when modifying therapy in virologically suppressed individuals, and when selecting a new regimen in patients with virologic failure
  • Evaluate candidacy for HIV PrEP and recommend appropriate regimens when indicated
  • Apply a sound knowledge of current directions in HIV cure research when counseling peers, patients, and policymakers


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.25 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 3.25 contact hours (0.325 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Numbers:

Advances in HIV Treatment: JA4008176-0000-22-199-L02-P / Application

Advances in HIV Prevention:  JA4008176-0000-22-200-L02-P / Application

Advances in HIV Cure:  JA4008176-0000-22-201-L02-P / Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.